{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:01:58Z","timestamp":1768010518772,"version":"3.49.0"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.prp.2025.155934","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T03:00:26Z","timestamp":1743390026000},"page":"155934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Translating preclinical insights into clinical strategies: Targeting cancer stem cells and stemness in prostate cancer"],"prefix":"10.1016","volume":"269","author":[{"given":"Najma","family":"Farahani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amin","family":"Maghsoodlou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadarian","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safa","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salman","family":"Daneshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzieh","family":"Ramezani Farani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Reza","family":"Yusefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Payman","family":"Rahimzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afshin","family":"Taheriazam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maliheh","family":"Entezari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrdad","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155934_bib1","doi-asserted-by":"crossref","unstructured":"Adamowicz, J., et al., Prostate cancer stem cells: from theory to practice. Scandinavian Journal of Urology, 2017. 51(2): p. 95-106.","DOI":"10.1080\/21681805.2017.1283360"},{"issue":"9","key":"10.1016\/j.prp.2025.155934_bib2","doi-asserted-by":"crossref","first-page":"7746","DOI":"10.3390\/ijms24097746","article-title":"Cancer stem cells and prostate cancer: a narrative review","volume":"24","author":"Al Salhi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib3","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.18632\/oncotarget.2953","article-title":"Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression","volume":"6","author":"Rybak","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib4","first-page":"19","article-title":"Prostate cancer stem cell biology","volume":"64","author":"Yu","year":"2012","journal-title":"Minerva Urol. Nefrol."},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/cancers11040434","article-title":"The contributions of prostate cancer stem cells in prostate cancer initiation and metastasis","volume":"11","author":"Mei","year":"2019","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.prp.2025.155934_bib6","doi-asserted-by":"crossref","first-page":"27433","DOI":"10.3390\/ijms161126036","article-title":"Prostate cancer stem cells: research advances","volume":"16","author":"Jaworska","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"10.1016\/j.prp.2025.155934_bib7","doi-asserted-by":"crossref","first-page":"14890","DOI":"10.3390\/ijms241914890","article-title":"Prostate cancer stem cells: biology and treatment implications","volume":"24","author":"Koukourakis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.prp.2025.155934_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s12015-008-9033-1","article-title":"Exploring the origins of the normal prostate and prostate cancer stem cell","volume":"4","author":"Kasper","year":"2008","journal-title":"Stem Cell Rev."},{"issue":"10","key":"10.1016\/j.prp.2025.155934_bib9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/stem.2859","article-title":"Concise review: prostate cancer stem cells: current understanding","volume":"36","author":"Skvortsov","year":"2018","journal-title":"Stem Cells"},{"issue":"11","key":"10.1016\/j.prp.2025.155934_bib10","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/onc.2010.530","article-title":"Revisiting the concept of cancer stem cells in prostate cancer","volume":"30","author":"Wang","year":"2011","journal-title":"Oncogene"},{"issue":"17","key":"10.1016\/j.prp.2025.155934_bib11","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1200\/JCO.2007.15.1472","article-title":"Prostate cancer stem cells: a new target for therapy","volume":"26","author":"Maitland","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/path.2478","article-title":"Prostate cancer stem cells","volume":"217","author":"Lang","year":"2009","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.prp.2025.155934_bib13","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12015-013-9453-4","article-title":"Searching for prostate cancer stem cells: markers and methods","volume":"9","author":"Sharpe","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"issue":"3","key":"10.1016\/j.prp.2025.155934_bib14","first-page":"242","article-title":"Cancer stem cells in prostate cancer","volume":"2","author":"Moltzahn","year":"2013","journal-title":"Transl. Androl. Urol."},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clgc.2012.01.002","article-title":"Prostate cancer stem cells","volume":"10","author":"Tu","year":"2012","journal-title":"Clin. Genitourin. Cancer"},{"issue":"21","key":"10.1016\/j.prp.2025.155934_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/gt.2008.101","article-title":"Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model","volume":"15","author":"Ren","year":"2008","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.prp.2025.155934_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3109\/07357907.2012.692171","article-title":"Human bone marrow-derived mesenchymal stem cells produced TGFbeta contributes to progression and metastasis of prostate cancer","volume":"30","author":"Ye","year":"2012","journal-title":"Cancer Investig."},{"key":"10.1016\/j.prp.2025.155934_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1471-2407-13-61","article-title":"Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression","volume":"13","author":"Fan","year":"2013","journal-title":"BMC Cancer"},{"issue":"19","key":"10.1016\/j.prp.2025.155934_bib19","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.18632\/oncotarget.2411","article-title":"TOP2Ahigh is the phenotype of recurrence and metastasis whereas TOP2Aneg cells represent cancer stem cells in prostate cancer","volume":"5","author":"Li","year":"2014","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.prp.2025.155934_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1593\/neo.11122","article-title":"Targeting of \u03b1(v)-integrins in stem\/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer","volume":"13","author":"van der Horst","year":"2011","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nm.2284","article-title":"The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44","volume":"17","author":"Liu","year":"2011","journal-title":"Nat. Med"},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib22","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000430350","article-title":"Pristimerin inhibits prostate cancer bone metastasis by targeting PC-3 stem cell characteristics and vegf-induced vasculogenesis of BM-EPCs","volume":"37","author":"Huang","year":"2015","journal-title":"Cell Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib23","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41419-020-2435-y","article-title":"CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating \u03b2-catenin\/STAT3 signaling","volume":"11","author":"Huang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.21037\/atm-20-1638","article-title":"Roles of NANOGP8 in cancer metastasis and cancer stem cell invasion during development of castration-resistant prostate cancer","volume":"9","author":"Sui","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"6","key":"10.1016\/j.prp.2025.155934_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.4103\/1735-5362.301340","article-title":"Alantolactone inhibits stem-like cell phenotype, chemoresistance and metastasis in PC3 cells through STAT3 signaling pathway","volume":"15","author":"Babaei","year":"2020","journal-title":"Res. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.prp.2025.155934_bib26","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.neo.2016.07.007","article-title":"DNMT1 regulates epithelial-mesenchymal transition and cancer stem cells, which promotes prostate cancer metastasis","volume":"18","author":"Lee","year":"2016","journal-title":"Neoplasia"},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib27","doi-asserted-by":"crossref","first-page":"11210","DOI":"10.1038\/s41598-021-90700-x","article-title":"NUMB suppression by miR-9\u20135\u2009P enhances CD44(+) prostate cancer stem cell growth and metastasis","volume":"11","author":"Wang","year":"2021","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.prp.2025.155934_bib28","first-page":"501","article-title":"Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages\/C-C motif chemokine ligand 5 pathway in tumor microenvironment","volume":"22","author":"Chen","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.prp.2025.155934_bib29","doi-asserted-by":"crossref","first-page":"14270","DOI":"10.1038\/ncomms14270","article-title":"MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes","volume":"8","author":"Liu","year":"2017","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/gtmb.2017.0179","article-title":"Curcumin suppresses in vitro proliferation and invasion of human prostate cancer stem cells by modulating DLK1-DIO3 imprinted gene cluster microRNAs","volume":"22","author":"Zhang","year":"2018","journal-title":"Genet Test. Mol. Biomark."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13046-025-03272-3","article-title":"AGD1\/USP10\/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer","volume":"44","author":"Wang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1871520617666170725165717","article-title":"Anethole inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and apoptosis","volume":"18","author":"Elkady","year":"2018","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.prp.2025.155934_bib33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.gene.2017.08.008","article-title":"Curcumin suppresses proliferation and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR","volume":"631","author":"Liu","year":"2017","journal-title":"Gene"},{"issue":"12","key":"10.1016\/j.prp.2025.155934_bib34","first-page":"4361","article-title":"miR-601 inhibits proliferation, migration and invasion of prostate cancer stem cells by targeting KRT5 to inactivate the Wnt signaling pathway","volume":"12","author":"Du","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"38","key":"10.1016\/j.prp.2025.155934_bib35","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1038\/s41388-018-0325-x","article-title":"Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate","volume":"37","author":"Liao","year":"2018","journal-title":"Oncogene"},{"issue":"65","key":"10.1016\/j.prp.2025.155934_bib36","doi-asserted-by":"crossref","first-page":"32435","DOI":"10.18632\/oncotarget.25945","article-title":"Integrin \u03b12\u03b21 decelerates proliferation, but promotes survival and invasion of prostate cancer cells","volume":"9","author":"Ojalill","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.155934_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2023.102078","article-title":"Regulatory mechanism of DHRS2-modified human umbilical cord mesenchymal stem cells-derived exosomes in prostate cancer cell proliferation and apoptosis","volume":"82","author":"Wu","year":"2023","journal-title":"Tissue Cell"},{"issue":"7","key":"10.1016\/j.prp.2025.155934_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/jfbc.13253","article-title":"Neferine inhibits proliferation and migration of human prostate cancer stem cells through p38 MAPK\/JNK activation","volume":"44","author":"Erdogan","year":"2020","journal-title":"J. Food Biochem."},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib39","first-page":"2550","article-title":"Targeting prostate cancer cell proliferation, stemness and metastatic potential using Costus speciosus derived phytochemicals","volume":"11","author":"Elkady","year":"2019","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.prp.2025.155934_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101170","article-title":"Autophagy in cancer development, immune evasion, and drug resistance","volume":"78","author":"Niu","year":"2025","journal-title":"Drug Resist. Updates"},{"issue":"11","key":"10.1016\/j.prp.2025.155934_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104161","article-title":"P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators","volume":"29","author":"Guo","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.prp.2025.155934_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216659","article-title":"Autophagy-driven regulation of cisplatin response in human cancers: exploring molecular and cell death dynamics","volume":"587","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.prp.2025.155934_bib43","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1158\/0008-5472.CAN-17-2332","article-title":"CXCL12\u03b3 promotes metastatic castration-resistant prostate cancer by inducing cancer stem cell and neuroendocrine phenotypes","volume":"78","author":"Jung","year":"2018","journal-title":"Cancer Res."},{"issue":"70","key":"10.1016\/j.prp.2025.155934_bib44","doi-asserted-by":"crossref","first-page":"115054","DOI":"10.18632\/oncotarget.23014","article-title":"YAP1 regulates prostate cancer stem cell-like characteristics to promote castration resistant growth","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.155934_bib45","doi-asserted-by":"crossref","first-page":"0252","DOI":"10.34133\/research.0252","article-title":"AZGP1P2\/UBA1\/RBM15 cascade mediates the fate determinations of prostate cancer stem cells and promotes therapeutic effect of docetaxel in castration-resistant prostate cancer via TPM1 m6A modification","volume":"6","author":"Wang","year":"2023","journal-title":"Research"},{"issue":"10","key":"10.1016\/j.prp.2025.155934_bib46","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.21873\/anticanres.14559","article-title":"Sphere-derived prostate cancer stem cells are resistant to \u03b3\u03b4 T cell cytotoxicity","volume":"40","author":"Miyashita","year":"2020","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib47","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/s41598-021-81126-6","article-title":"CD117\/c-kit defines a prostate CSC-like subpopulation driving progression and TKI resistance","volume":"11","author":"Harris","year":"2021","journal-title":"Sci. Rep."},{"issue":"91","key":"10.1016\/j.prp.2025.155934_bib48","doi-asserted-by":"crossref","first-page":"36273","DOI":"10.18632\/oncotarget.26345","article-title":"The estrogen receptor variants \u03b22 and \u03b25 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling","volume":"9","author":"Faria","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.155934_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2018.05.014","article-title":"Acquisition of tumorigenic potential and therapeutic resistance in CD133+\u2009subpopulation of prostate cancer cells exhibiting stem-cell like characteristics","volume":"430","author":"Kanwal","year":"2018","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib50","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1007\/s11033-021-06387-w","article-title":"Sonic hedgehog signaling is associated with resistance to zoledronic acid in CD133high\/CD44high prostate cancer stem cells","volume":"48","author":"Acikgoz","year":"2021","journal-title":"Mol. Biol. Rep."},{"issue":"12","key":"10.1016\/j.prp.2025.155934_bib51","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/stem.3281","article-title":"CD44(+) cells determine fenofibrate-induced microevolution of drug-resistance in prostate cancer cell populations","volume":"38","author":"Wr\u00f3bel","year":"2020","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.prp.2025.155934_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063291","article-title":"Microbiome dysbiosis is associated with castration resistance and cancer stemness in metastatic prostate cancer","volume":"25","author":"Uzelac","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"36","key":"10.1016\/j.prp.2025.155934_bib53","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1038\/onc.2011.114","article-title":"NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation","volume":"30","author":"Jeter","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2025.155934_bib54","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2023.09.032","article-title":"Doxorubicin-induced senescence promotes resistance to cell death by modulating genes associated with apoptotic and necrotic pathways in prostate cancer DU145 CD133(+)\/CD44(+) cells","volume":"680","author":"Tatar","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.prp.2025.155934_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.594023","article-title":"Cell plasticity-related phenotypes and taxanes resistance in castration-resistant prostate cancer","volume":"10","author":"Jim\u00e9nez","year":"2020","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2025.155934_bib56","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.7150\/ijbs.41686","article-title":"Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K\/Akt signaling pathways","volume":"16","author":"Lu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"6","key":"10.1016\/j.prp.2025.155934_bib57","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3892\/ijo.2015.3202","article-title":"Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA\/mTOR\/HIF-1\u03b1 signaling","volume":"47","author":"Du","year":"2015","journal-title":"Int. J. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2025.155934_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043726","article-title":"Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF","volume":"7","author":"Bao","year":"2012","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.prp.2025.155934_bib59","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.3892\/or.2015.3708","article-title":"Inhibitory action of pristimerin on hypoxia\u2011mediated metastasis involves stem cell characteristics and EMT in PC-3 prostate cancer cells","volume":"33","author":"Zuo","year":"2015","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.prp.2025.155934_bib60","first-page":"1078","article-title":"Hypoxia regulates SOX2 expression to promote prostate cancer cell invasion and sphere formation","volume":"6","author":"Bae","year":"2016","journal-title":"Am. J. Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2025.155934_bib61","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1007\/s12094-023-03093-w","article-title":"Hypoxia promotes conversion to a stem cell phenotype in prostate cancer cells by activating HIF-1\u03b1\/Notch1 signaling pathway","volume":"25","author":"Wu","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2025.155934_bib62","first-page":"3784","article-title":"Shikonin enhances the antitumor effect of cabazitaxel in prostate cancer stem cells and reverses cabazitaxel resistance by inhibiting ABCG2 and ALDH3A1","volume":"10","author":"Wang","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib63","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10520295.2017.1387286","article-title":"Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosis","volume":"93","author":"Rouhrazi","year":"2018","journal-title":"Biotech. Histochem."},{"issue":"8","key":"10.1016\/j.prp.2025.155934_bib64","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/a-1867-4805","article-title":"Curcumin upregulates miR-148a to increase the chemosensitivity of CD44-positive prostate cancer stem cells to paclitaxel through targeting the MSK1\/IRS1 axis","volume":"72","author":"Vatankhah","year":"2022","journal-title":"Drug Res."},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/pros.24632","article-title":"Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer","volume":"84","author":"Wang","year":"2024","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib66","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/ptr.6563","article-title":"Capsaicin suppressed activity of prostate cancer stem cells by inhibition of Wnt\/\u03b2-catenin pathway","volume":"34","author":"Zhu","year":"2020","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s42003-020-0750-6","article-title":"Chemosensitization of prostate cancer stem cells in mice by angiogenin and plexin-B2 inhibitors","volume":"3","author":"Li","year":"2020","journal-title":"Commun. Biol."},{"issue":"12","key":"10.1016\/j.prp.2025.155934_bib68","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.31557\/APJCP.2021.22.12.3823","article-title":"Role of resveratrol as radiosensitizer by targeting cancer stem cells in radioresistant prostate cancer cells (PC-3)","volume":"22","author":"El-Benhawy","year":"2021","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib69","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.canlet.2013.10.003","article-title":"Rottlerin induces autophagy and apoptosis in prostate cancer stem cells via PI3K\/Akt\/mTOR signaling pathway","volume":"343","author":"Kumar","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.prp.2025.155934_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110216","article-title":"Effects of sulforaphane on prostate cancer stem cells-like properties: In vitro and molecular docking studies","volume":"762","author":"Xuan","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.prp.2025.155934_bib71","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/mc.23406","article-title":"Transcriptome profiling reveals that VNPP433-3\u03b2, the lead next-generation galeterone analog inhibits prostate cancer stem cells by downregulating epithelial-mesenchymal transition and stem cell markers","volume":"61","author":"Thomas","year":"2022","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib72","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1002\/jcb.26572","article-title":"GANT-61 and GDC-0449 induce apoptosis of prostate cancer stem cells through a GLI-dependent mechanism","volume":"119","author":"Tong","year":"2018","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.prp.2025.155934_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116699","article-title":"Lupeol, an androgen receptor inhibitor, enhances the chemosensitivity of prostate cancer stem cells to antiandrogen enzalutamide-based therapy","volume":"478","author":"Khan","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"29","key":"10.1016\/j.prp.2025.155934_bib74","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1016\/j.biomaterials.2011.05.089","article-title":"Dual docetaxel\/superparamagnetic iron oxide loaded nanoparticles for both targeting magnetic resonance imaging and cancer therapy","volume":"32","author":"Ling","year":"2011","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.prp.2025.155934_bib75","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1166\/jbn.2021.3172","article-title":"Anticancer activity of sweroside nanoparticles in prostate cancer bone metastasis in PC-3 cells involved in Wnt\/\u03b2-catenin signaling pathway","volume":"17","author":"Huang","year":"2021","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.prp.2025.155934_bib76","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.actbio.2019.07.003","article-title":"DNA vaccination via RALA nanoparticles in a microneedle delivery system induces a potent immune response against the endogenous prostate cancer stem cell antigen","volume":"96","author":"Cole","year":"2019","journal-title":"Acta Biomater."},{"issue":"19","key":"10.1016\/j.prp.2025.155934_bib77","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1039\/D0NR08024A","article-title":"Doxorubicin and PD-L1 siRNA co-delivery with stem cell membrane-coated polydopamine nanoparticles for the targeted chemoimmunotherapy of PCa bone metastases","volume":"13","author":"Mu","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.prp.2025.155934_bib78","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.2147\/IJN.S32804","article-title":"Prostate stem cell antigen-targeted nanoparticles with dual functional properties: in vivo imaging and cancer chemotherapy","volume":"7","author":"Gao","year":"2012","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib79","first-page":"71","article-title":"E-cadherin plasticity in prostate cancer stem cell invasion","volume":"1","author":"Bae","year":"2011","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-014-0064-x","article-title":"Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM","volume":"16","author":"Deng","year":"2015","journal-title":"BMC Immunol."},{"issue":"10","key":"10.1016\/j.prp.2025.155934_bib81","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pros.23989","article-title":"THBS4 silencing regulates the cancer stem cell-like properties in prostate cancer via blocking the PI3K\/Akt pathway","volume":"80","author":"Hou","year":"2020","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib82","doi-asserted-by":"crossref","first-page":"13523","DOI":"10.1038\/s41598-024-60052-3","article-title":"GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior","volume":"14","author":"Bhat","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib83","doi-asserted-by":"crossref","first-page":"2393442","DOI":"10.1080\/2162402X.2024.2393442","article-title":"Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NF\u03baB-signaling","volume":"13","author":"Kainulainen","year":"2024","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.prp.2025.155934_bib84","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1002\/ijc.32323","article-title":"BRCA1 and EZH2 cooperate in regulation of prostate cancer stem cell phenotype","volume":"145","author":"Gorodetska","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib85","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.18632\/oncotarget.6643","article-title":"Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.155934_bib86","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.biopha.2018.01.086","article-title":"miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and GSK3\u03b2","volume":"99","author":"Song","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib87","doi-asserted-by":"crossref","DOI":"10.1242\/bio.059615","article-title":"Metabolic shift towards oxidative phosphorylation reduces cell-density-induced cancer-stem-cell-like characteristics in prostate cancer in vitro","volume":"12","author":"Lai","year":"2023","journal-title":"Biol. Open"},{"issue":"4","key":"10.1016\/j.prp.2025.155934_bib88","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.bbrc.2016.05.017","article-title":"Saikosaponin-d: A potential chemotherapeutics in castration resistant prostate cancer by suppressing cancer metastases and cancer stem cell phenotypes","volume":"474","author":"Zhong","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.prp.2025.155934_bib89","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3892\/ijo.2017.3964","article-title":"Overexpression of secretory phospholipase A2-IIa supports cancer stem cell phenotype via HER\/ERBB-elicited signaling in lung and prostate cancer cells","volume":"50","author":"Lu","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib90","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10637-019-00774-8","article-title":"Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-\u03baB","volume":"38","author":"Erdogan","year":"2020","journal-title":"Investig. N. Drugs"},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib91","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3892\/ijo.2015.3270","article-title":"N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells","volume":"48","author":"Wang","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2025.155934_bib92","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.7314\/APJCP.2012.13.5.1943","article-title":"p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression","volume":"13","author":"Ferronika","year":"2012","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.prp.2025.155934_bib93","doi-asserted-by":"crossref","first-page":"1481375","DOI":"10.3389\/fmolb.2024.1481375","article-title":"NUF2 is associated with cancer stem cell characteristics and a potential drug target for prostate cancer","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Mol. Biosci."},{"issue":"8","key":"10.1016\/j.prp.2025.155934_bib94","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1111\/jcmm.13637","article-title":"ZEB1-mediated vasculogenic mimicry formation associates with epithelial-mesenchymal transition and cancer stem cell phenotypes in prostate cancer","volume":"22","author":"Wang","year":"2018","journal-title":"J. Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.prp.2025.155934_bib95","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/0008-5472.CAN-18-1753","article-title":"Constant degradation of the androgen receptor by MDM2 conserves prostate cancer stem cell integrity","volume":"79","author":"Vummidi Giridhar","year":"2019","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib96","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13046-017-0560-y","article-title":"PHF21B overexpression promotes cancer stem cell-like traits in prostate cancer cells by activating the Wnt\/\u03b2-catenin signaling pathway","volume":"36","author":"Li","year":"2017","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"2","key":"10.1016\/j.prp.2025.155934_bib97","first-page":"1821","article-title":"MicroRNA-218 inhibits the migration, epithelial-mesenchymal transition and cancer stem cell properties of prostate cancer cells","volume":"16","author":"Guan","year":"2018","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.prp.2025.155934_bib98","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/19768354.2021.1987320","article-title":"UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3\u2005K\/Akt signaling pathway in prostate cancer cells","volume":"25","author":"Lee","year":"2021","journal-title":"Anim. Cells Syst."},{"issue":"1","key":"10.1016\/j.prp.2025.155934_bib99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.7150\/thno.16752","article-title":"CD54-NOTCH1 axis controls tumor initiation and cancer stem cell functions in human prostate cancer","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T14:48:01Z","timestamp":1749221281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":99,"alternative-id":["S0344033825001268"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155934","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translating preclinical insights into clinical strategies: Targeting cancer stem cells and stemness in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155934","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155934"}}